Clinical analysis reveals a positive correlation between LOXL4 expression in CD68+ cells and PD-L1 levels in human HCC tissue, while high LOXL4 expression in CD68+ cells and low CD8A expression in tumor tissue serve as predictive markers for poor survival in HCC patients [102]. Here, LOXL4 is linked to hepatocellular carcinoma.